Evidence map›Paper›PMID 34429063›Full record

ArticleBMC microbiology2021

Mother-to-infant transmission of the carcinogenic colibactin-producing bacteria.

Yuta Tsunematsu, Koji Hosomi, Jun Kunisawa, Michio Sato, Noriko Shibuya, Emiko Saito, Haruka Murakami, Yuko Yoshikawa, Yuji Iwashita, Noriyuki Miyoshi and 6 more

Abstract read
In one paragraph

Article in BMC microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. The microbial landscape of colorectal cancer.Nature reviews. Microbiology · 2024
    Review
  4. Article
  5. Article
  6. Does month of birth influence colorectal cancer prognosis?Langenbeck's archives of surgery · 2023
    Observational
  7. Review
  8. Screening method toward ClbP-specific inhibitors.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. A Probiotic Friend.mSphere · 2021
    Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yuta TsunematsuDepartment of Pharmaceutical Sciences, University of Shizuoka, 422-8526, Shizuoka, Japan.
Koji HosomiLaboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research, Laboratory of Gut Environmental System, Health and Nutrition (NIBIOHN), National Institutes of Biomedical Innovation, 567-0085, Ibaraki-city, Japan.
Jun KunisawaLaboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research, Laboratory of Gut Environmental System, Health and Nutrition (NIBIOHN), National Institutes of Biomedical Innovation, 567-0085, Ibaraki-city, Japan.
Michio SatoDepartment of Pharmaceutical Sciences, University of Shizuoka, 422-8526, Shizuoka, Japan.
Noriko ShibuyaDepartment of Pediatrics, Maternal and Child Health Center, Aiiku Clinic, 106-8580, Tokyo, Japan.
Emiko SaitoDepartment of Human Nutrition, Tokyo Kasei Gakuin University, 194-0292, Tokyo, Japan.
Haruka MurakamiDepartment of Physical Activity Research, Health and Nutrition (NIBIOHN), National Institutes of Biomedical Innovation, 162-8636, Tokyo, Japan.
Yuko YoshikawaSchool of Veterinary Medicine, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, 180-8602, Tokyo, Japan.
Yuji IwashitaDepartment of Tumor Pathology, Hamamatsu University School of Medicine, 431- 3192, Shizuoka, Japan.
Noriyuki MiyoshiGraduate School of Nutritional and Environmental Sciences, University of Shizuoka, 422-8526, Shizuoka, Japan.
Michihiro MutohDepartment of Molecular-Targeting Cancer Prevention, Kyoto Prefectural University of Medicine, 602-8566, Kyoto, Japan.
Hideki IshikawaDepartment of Molecular-Targeting Cancer Prevention, Kyoto Prefectural University of Medicine, 602-8566, Kyoto, Japan.
Haruhiko SugimuraDepartment of Tumor Pathology, Hamamatsu University School of Medicine, 431- 3192, Shizuoka, Japan.
Motohiko MiyachiDepartment of Physical Activity Research, Health and Nutrition (NIBIOHN), National Institutes of Biomedical Innovation, 162-8636, Tokyo, Japan.
Keiji WakabayashiGraduate School of Nutritional and Environmental Sciences, University of Shizuoka, 422-8526, Shizuoka, Japan.
Kenji WatanabeDepartment of Pharmaceutical Sciences, University of Shizuoka, 422-8526, Shizuoka, Japan. kenji55@u-shizuoka-ken.ac.jp.ORCID 0000-0002-0463-4831

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Escherichia coli strain that is known to produce the genotoxic secondary metabolite colibactin is linked to colorectal oncogenesis. Therefore, understanding the properties of such colibactin-positive E. coli and the molecular mechanism of oncogenesis by colibactin may provide us with opportunities for early diagnosis or prevention of colorectal oncogenesis. While there have been major advances in the characterization of colibactin-positive E. coli and the toxin it produces, the infection route of the clb + strain remains poorly characterized.

resultsWe examined infants and their treatments during and post-birth periods to examine potential transmission of colibactin-positive E. coli to infants. Here, analysis of fecal samples of infants over the first month of birth for the presence of a colibactin biosynthetic gene revealed that the bacterium may be transmitted from mother to infant through intimate contacts, such as natural childbirth and breastfeeding, but not through food intake.

conclusionsOur finding suggests that transmission of colibactin-positive E. coli appears to be occurring at the very early stage of life of the newborn and hints at the possibility of developing early preventive measures against colorectal cancer.

Indexed as

Infectious Disease Transmission, VerticalBacterial ToxinsCarcinogenesisCarcinogensColorectal NeoplasmsEscherichia coliEscherichia coli InfectionsFecesFemaleHumansInfant, NewbornMaleMothersPeptidesPolyketidesBacterial ToxinsCarcinogenscolibactinPeptidesPolyketidesColibactinColorectal cancerEscherichia coliNatural productPerinatal transmission

Identifiers

PMID34429063
PMCPMC8386082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.